Theravance Biopharma, Inc. (TBPH) Cash Flow Annual - Discounting Cash Flows
TBPH
Theravance Biopharma, Inc.
TBPH (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
Report Filing: 2025-11-12 2025-03-07 2024-03-01 2023-03-01 2022-02-28 2021-02-26 2020-02-27 2019-02-28 2018-02-28 2017-03-01 2016-03-11 2015-03-13 2013-12-31 2012-12-31 2011-12-31
Net Income/Starting Line 29.34 -56.42 -55.19 -92.82 -265.1 -294.8 -236.5 -215.5 -285.4 -190.7 -182.2 -237 -156.3 -9.57 -109.3
Cash From Operating Activities 243.7 -11.54 -27 -187 -207.9 -250.4 -238.2 -112.9 -201.1 -98.99 -168.9 -175.2 -121 -119.1 -83.43
Depreciation and Amortization 3.31 3.62 4.26 7.02 8.6 6.97 6.21 3.17 4.03 3.12 2.99 2.66 2.65 3.25 3.84
Deferred Income Tax -18.14 -7.57 3.21 0 0 0 0 -11.21 8.74 0.282 2.17 0 0 0 0
Stock Based Compensation 19.82 21.39 25.37 39.73 62.06 62.98 60.45 51.31 49.15 41.17 54.05 43.23 22.48 21.32 0
Other Non-Cash Items 2.62 7.09 3.7 -183.3 26.1 12.25 -23.01 -0.043 0.01 0.182 -8.06 3.22 0.02 0.196 23.91
Changes in Working Capital 206.7 20.36 -8.34 42.35 -39.55 -37.78 -45.4 59.43 22.43 46.93 -37.78 12.77 10.18 -134.3 -1.84
Accounts Receivable 48.58 -0.966 0 -2.72 1.8 6.13 -15.02 1.63 -1.61 1.28 -1.63 -0.09 -0.199 -2.71 1.3
Inventory 0 0 0 0 0 0 0 -1.63 -7.3 -3.18 1.03 -6.63 -3.1 -4.82 1.71
Accounts Payable 0.759 0.75 0.006 -1.61 -3.53 3.66 -4.27 3.58 3.8 -16.44 8.72 3.92 2.11 -1.53 3.31
Deferred Revenue 157.4 20.57 -8.35 46.68 -37.82 -47.56 -26.1 55.85 27.54 65.27 -45.9 15.57 11.36 -125.2 -8.17
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities -90.19 12.28 -32.7 1,154 124.5 10.72 -83.05 176.7 -56.33 -148.2 111 -106.3 -2.63 -2.43 -3.05
Investments in Property Plant and Equipment -0.224 -0.332 -2.49 -0.572 -3.41 -6.62 -3.18 -7.24 -2.41 -2.13 -2.65 -3.11 -2.73 -2.59 -3.63
Payments for Acquisitions 0 0 0 0 0 0 5 20 0 0 0 0 0 0 0
Purchases of Securities -223.3 -143 -134.5 -103.1 -158.3 -402 -423.9 -183.3 -288.8 -237.6 -73.01 -168.9 0 0 0
Sales and Maturities of Investments 133.3 155.7 102.8 158 286.2 419.3 339 347.2 234.9 91.47 186.7 66.44 0 0 0
Other Investing Activities 0 0 1.51 1,100 0.006 0.064 0.005 0.017 -53.93 -146.1 113.7 -0.693 0.1 0.16 0.575
Cash From Financing Activities -2.12 -2.5 -198.9 -758.8 91.86 263.1 1.29 225.2 1.66 479.2 81.31 370.6 123.6 121.5 86.48
Debt Repayment 0 0 0 -631.6 -10.73 144.7 -2.15 229.4 0 222.5 0 0 0 -0.069 -0.206
Common Stock Issued 0.328 0.099 0 0 108.2 139.9 0 0 0 253 79.02 0 0 0 0
Common Stock Repurchased -2.58 -3.1 -199.6 -132.3 -9.06 -9.75 -3.17 -9.81 -8.56 -3.87 -0.756 -0.178 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.133 0.508 0.618 5.08 3.47 -11.73 6.62 5.57 10.22 7.57 3.05 370.8 123.6 121.6 86.69
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0 0 0 0 281.4 0 0 0
Net Change in Cash 136.1 -1.75 -258.6 208.2 8.5 23.4 -320 289 -255.7 232 23.49 370.6 0 0 0
Cash at Beginning of Period 38.63 40.38 299 90.8 82.3 58.9 378.9 89.81 344.7 112.7 89.22 -281.4 0 0 0
Cash at End of Period 174.8 38.63 40.38 299 90.8 82.3 58.9 378.9 88.98 344.7 112.7 89.22 0 0 0
Free Cash Flow 243.5 -11.87 -29.48 -187.6 -211.3 -257 -241.4 -120.1 -203.5 -101.1 -171.5 -178.3 -123.7 -121.7 -87.06
Operating Cash Flow 243.7 -11.54 -27 -187 -207.9 -250.4 -238.2 -112.9 -201.1 -98.99 -168.9 -175.2 -121 -119.1 -83.43
Capital Expenditure -0.224 -0.332 -2.49 -0.572 -3.41 -6.62 -3.18 -7.24 -2.41 -2.13 -2.65 -3.11 -2.73 -2.59 -3.63
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program